Problems in developing a vaccine against coronavirus reported in Germany

click fraud protection
13 July 2020 21:00Alla Lysak
Problems in developing a vaccine against coronavirus reported in Germany

Problems in developing a vaccine against coronavirus reported in Germany

The COVID-19 vaccine, which the whole world is eagerly awaiting, may not be effective.

Research by scientists shows that over time, the amount of antibodies produced by a patient decreases. It means that vaccine with a high degree of probability will not be able to protect a person from re-infection with the coronavirus COVID-19.

According to Handelsblatt, in humans, two types of cells are responsible for immunity, B-lymphocytes and T-lymphocytes. Over time, the number of B-lymphocytes (antibodies) decreases, but the T-cells remain able to fight the virus.

It is not entirely clear how this discovery will affect the strategy for developing a vaccine, but further research in this direction is needed, experts say. Even if a new vaccine can create immunity in a person against coronavirus, its short duration may become the main problem.

Recall

  • the experts told how to wear high-heeled shoes.
  • instagram viewer
  • woman with coronavirus gave birth to twins with pneumonia.
  • doctors have named an easy way to keep the heart healthy.
Instagram story viewer